Skip to main content
Syncona Limited logo

Syncona Limited — Investor Relations & Filings

Ticker · SYNC ISIN · GG00B8P59C08 LEI · 213800X8MBI5VQITLW60 IL Financial and insurance activities
Open in API
Filings indexed 1,029 across all filing types
Latest filing 2025-02-04 Regulatory Filings
Country GG Guernsey
Listing IL SYNC

About Syncona Limited

https://www.synconaltd.com/

Syncona Limited is a life science investment company focused on founding, building, and funding a portfolio of healthcare businesses. The company's strategy is to identify and advance exceptional science to create globally leading companies capable of delivering transformational treatments to patients, particularly in areas with high unmet medical needs. Its portfolio is concentrated in innovative therapeutic areas, including gene therapy, cell therapy, and biologics. Syncona actively manages its companies to reach key value inflection points, aiming to generate significant long-term capital appreciation for shareholders through strategic events such as mergers, acquisitions, and other liquidity events.

Recent filings

Filing Released Lang Actions
Spur announced positive data from Phase I/II trial
Regulatory Filings Classification · 1% confidence The document is an announcement by Syncona Limited regarding positive Phase I/II trial data for its portfolio company, Spur Therapeutics' gene therapy candidate FLT201 for Gaucher disease. The announcement details clinical results, safety profiles, regulatory feedback (FDA alignment for accelerated approval), and future trial plans (Phase III initiation). This type of communication, which releases key financial/operational updates and clinical milestones, is characteristic of an Earnings Release (ER) or a general Regulatory Filing (RNS). Since it contains detailed operational and clinical data updates rather than just a summary of quarterly financials, and it is clearly a formal announcement disseminated via RNS (indicated by the RNS Number header), it fits best as a general Regulatory Filing (RNS). It is not a full Annual Report (10-K), an Interim Report (IR), or a specific management discussion (MDA). Given the context of being an RNS announcement, RNS is the most appropriate general classification.
2025-02-04 English
Transaction in Own Shares
Transaction in Own Shares Classification · 1% confidence The document explicitly announces a 'Transaction in Own Shares' where the company purchased 150,000 ordinary shares as part of a previously announced share buyback programme. It details the date, price, and resulting treasury share count and total voting rights. This directly corresponds to the definition of a company buying back or selling its own shares, which maps to the 'Transaction in Own Shares' category (POS). Although it is distributed via RNS, the specific content dictates the POS classification over the general RNS fallback.
2025-02-04 English
Total Voting Rights
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is a formal announcement disseminated via RNS (Regulatory News Service) of the London Stock Exchange, indicated by the 'RNS Number' and the concluding boilerplate text referencing RNS and the FCA. The core content announces the 'Total Voting Rights' as of a specific date (3 February 2025, referencing 31 January 2025 data) pursuant to DTR 5.6.1. This type of announcement, detailing the total number of shares in issue and voting rights, is a mandatory regulatory disclosure. While it relates to share capital, it is not a general share issue (SHA) or a transaction in own shares (POS), but rather a periodic disclosure required by transparency rules. Since it is a specific regulatory update that doesn't fit the other precise categories (like DIRS, DIV, or ER), and it is a formal regulatory notification, it falls best under the general 'Regulatory Filings' category (RNS) as a catch-all for required disclosures not otherwise specified, or potentially DVA if it were voting results, but here it is about the denominator for voting rights calculation. Given the options, RNS is the most appropriate general regulatory filing code for this type of mandatory disclosure.
2025-02-03 English
Transaction in Own Shares
Transaction in Own Shares Classification · 1% confidence The document explicitly states the subject is 'Transaction in Own Shares' and details the purchase of ordinary shares by the company as part of a 'share buyback programme'. It provides specific trade details (date, volume, price) and updates the total voting rights after treasury shares are accounted for. This directly corresponds to the definition of 'Transaction in Own Shares' (Code: POS). The presence of 'RNS Number' and the footer referencing RNS/London Stock Exchange confirms it is a regulatory announcement, but the specific content dictates the POS classification over the general RNS fallback.
2025-02-03 English
Transaction in Own Shares
Transaction in Own Shares Classification · 1% confidence The document explicitly announces a 'Transaction in Own Shares' and details the purchase of 150,000 Ordinary Shares as part of a 'share buyback programme'. It provides the date of purchase, prices, and the resulting change in total voting rights. This directly corresponds to the definition of a company buying back or selling its own shares, which maps to the 'Transaction in Own Shares' category (POS). The presence of the RNS Number and the closing statement about RNS being the news service of the London Stock Exchange confirms it is a regulatory announcement, but the specific content dictates the POS classification over the general RNS fallback.
2025-01-31 English
Transaction in Own Shares
Transaction in Own Shares Classification · 1% confidence The document explicitly states the subject is 'Transaction in Own Shares' and details the purchase of ordinary shares by the company on a specific date (29 January 2025) as part of a 'share buyback programme'. This directly corresponds to the definition of 'Transaction in Own Shares' (Code: POS). The presence of the RNS Number and the closing statement referencing RNS as the Primary Information Provider confirms it is a regulatory announcement, but the specific content dictates the POS classification over the general RNS fallback.
2025-01-30 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.